Drug Information

Drug General Information
Drug ID
D0XB1M
Former ID
DIB008556
Drug Name
MSH-372
Synonyms
MIV-150; MIV-150)
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 1 [524596]
Company
Medivir AB
Formula
C19H17FN4O3
Canonical SMILES
[C@@H]1([C@H](C1)NC(=O)Nc1ccc(cn1)C#N)c1c(c(ccc1F)C(=O)<br />CC)O
PubChem Compound ID
468179
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Inhibitor [550939]
References
Ref 524596ClinicalTrials.gov (NCT02033109) Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use. U.S. National Institutes of Health.
Ref 550939WO patent application no. 2004,0290,42, Pyrazole derivatives as reverse transcriptase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.